CAGGIA, Federica
 Distribuzione geografica
Continente #
NA - Nord America 3.597
EU - Europa 2.297
AS - Asia 2.055
SA - Sud America 327
AF - Africa 62
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.347
Nazione #
US - Stati Uniti d'America 3.519
SG - Singapore 669
CN - Cina 554
DE - Germania 534
GB - Regno Unito 506
IT - Italia 406
VN - Vietnam 246
BR - Brasile 240
HK - Hong Kong 227
SE - Svezia 163
IE - Irlanda 137
FI - Finlandia 132
RU - Federazione Russa 129
FR - Francia 75
UA - Ucraina 72
IN - India 64
KR - Corea 59
ID - Indonesia 40
TR - Turchia 39
AR - Argentina 34
CA - Canada 32
MX - Messico 30
NL - Olanda 30
BD - Bangladesh 26
BG - Bulgaria 25
JP - Giappone 17
PL - Polonia 17
CO - Colombia 16
IQ - Iraq 14
ZA - Sudafrica 14
MA - Marocco 13
CL - Cile 12
ES - Italia 11
LT - Lituania 11
SA - Arabia Saudita 11
EC - Ecuador 10
KE - Kenya 10
AE - Emirati Arabi Uniti 9
AT - Austria 8
EG - Egitto 8
VE - Venezuela 8
CH - Svizzera 7
CZ - Repubblica Ceca 7
PH - Filippine 7
PK - Pakistan 7
TH - Thailandia 7
SY - Repubblica araba siriana 6
TW - Taiwan 6
IR - Iran 5
JO - Giordania 5
MY - Malesia 5
LB - Libano 4
NP - Nepal 4
SI - Slovenia 4
AU - Australia 3
BE - Belgio 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
IL - Israele 3
MK - Macedonia 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BI - Burundi 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
HT - Haiti 1
LU - Lussemburgo 1
Totale 8.336
Città #
Ashburn 449
Singapore 425
Santa Clara 327
Southend 297
Hong Kong 221
Chandler 215
San Jose 185
Hefei 178
Fairfield 174
Woodbridge 164
Dublin 137
Munich 130
Beijing 112
Houston 109
Jacksonville 108
Nyköping 107
Dearborn 101
Dallas 100
Helsinki 96
Los Angeles 96
Wilmington 86
Ho Chi Minh City 85
Chicago 84
Seattle 74
New York 70
London 69
Cambridge 67
Seoul 59
Modena 50
Hanoi 49
Council Bluffs 47
The Dalles 41
Salt Lake City 37
Lauterbourg 33
Enfield 32
Fremont 32
Ann Arbor 31
Bologna 30
Jakarta 27
Shanghai 26
Milan 25
Princeton 23
Sofia 22
San Diego 21
Orem 20
São Paulo 20
Eugene 19
Rome 19
Moscow 18
Phoenix 17
Tampa 17
Bremen 15
Buffalo 15
Turku 15
Frankfurt am Main 14
Reggio Emilia 14
Chennai 13
Elk Grove Village 13
Falls Church 13
Izmir 13
Atlanta 12
Columbus 11
Da Nang 11
Des Moines 11
Guangzhou 11
Stockholm 11
Tokyo 11
Istanbul 10
Lancaster 10
Mexico City 10
Nairobi 10
Nanjing 10
Redondo Beach 10
Denver 9
Dong Ket 9
Johannesburg 9
Kent 9
Parma 9
Poplar 9
Redwood City 9
Warsaw 9
Dhaka 8
Haiphong 8
Manchester 8
Baghdad 7
Boardman 7
Brooklyn 7
Montreal 7
Nuremberg 7
Ottawa 7
Querétaro 7
San Francisco 7
Amsterdam 6
Brasília 6
Cardiff 6
Haarlem 6
Hải Dương 6
Kunming 6
Lappeenranta 6
Miami 6
Totale 5.444
Nome #
Early neonatal inflammation affects adult pain reactivity and anxiety related traits in mice: genetic background counts 571
Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats 420
Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain 382
Stress induces altered CRE/CREB pathway activity and BDNF expression in the hippocampus of glucocorticoid receptor-impaired mice 379
Clinical and molecular analysis of long-term HER2 positive metastatic breast cancer survivors. 372
Central effects of a local inflammation in three commonly used mouse strains with a different anxious phenotype 359
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 339
Quality of life and anxious-depressive symptoms in cancer patients undergoing mindfulness-based interventions: Feasibility and preliminary outcomes on prospective single-centre case-control study (MIND4ME St.) 323
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 315
Impaired stress-induced regulation of brain derived neurotrophic factor expression in hippocampus of glucocorticoid receptor impaired mice: Model of depression 310
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status 305
Impact of time to surgery after neoadjuvant chemotherapy in patients with operable breast cancer. 303
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 299
Molecular effects of subchronic andchronic treatment with escitalopram inthe rat central nervous system 286
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 282
Gene expression profile of the hippocampus of a behavioural model of depression 281
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 278
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy 273
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 271
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status. 254
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 254
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges 245
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 218
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 201
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 201
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes 161
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 150
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 137
A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA) 135
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019 51
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments. 30
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer 17
Totale 8.402
Categoria #
all - tutte 28.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.756


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202177 0 0 0 0 0 0 0 0 0 0 43 34
2021/2022387 18 47 14 25 18 29 15 10 38 43 75 55
2022/2023759 66 92 46 71 48 69 12 57 170 9 85 34
2023/2024489 19 23 33 70 72 49 55 50 11 17 33 57
2024/20251.643 39 22 40 101 265 226 181 118 184 104 143 220
2025/20263.145 256 139 298 408 641 223 384 160 300 336 0 0
Totale 8.402